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Introduction: Both hyperkalemia and pseudohyperkalemia occur in the emergency department. 
True hyperkalemia necessitates emergent treatment while pseudohyperkalemia requires recognition 
to prevent inappropriate treatment. It is imperative that the emergency physician (EP) have an 
understanding of the causes and clinical presentations of both phenomena. 
Case Report: We present a case of an 88-year-old male with chronic lymphocytic leukemia (CLL) 
and suspected blast crisis who was found to have elevated serum potassium levels without other 
manifestations of hyperkalemia and eventually was determined to have pseudohyperkalemia due to 
white cell fragility. 
Discussion: Differentiation of hyperkalemia and pseudohyperkalemia is a critical skill for the EP. 
We discuss multiple causes of hyperkalemia and pseudohyperkalemia in an effort to broaden the 
knowledge base.
Conclusion: We present a case of CLL as an unusual cause of pseudohyperkalemia and review 
common causes of pseudohyperkalemia. [Clin Pract Cases Emerg Med. 2020;4(2):208–210.] 
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INTRODUCTION
Hyperkalemia is a potentially life-threatening electrolyte 
derangement that requires early diagnosis and prompt 
treatment to prevent significant morbidity and mortality. 
Pseudohyperkalemia is an in vitro increase in serum potassium 
without in vivo increase and thus lacks clinical manifestations 
of hyperkalemia.1 Every emergency physician (EP) has 
encountered pseudohyperkalemia as a result of hemolysis 
from pre-analytical errors.2 Fortunately, the laboratory usually 
identifies hemolysis at the time of reporting. We present a 
case of pseudohyperkalemia without apparent hemolysis in 
a patient with chronic lymphocytic leukemia (CLL), and we 
present a review of pseudohyperkalemia in the literature.
 
CASE REPORT
An 88-year-old male with baseline dementia and known CLL 
diagnosed in 2016 (although he had not been receiving treatment) 
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initially presented to an outside hospital with bilateral lower 
extremity edema. There, he was found to have a white blood cell 
count of 280,000 cells per microliter (cells/μL) (reference range: 
4,400-10,400 cells/μL), an increase from 120,000 cells/μL 10 
months prior. He was subsequently transferred due to concerns 
for transformation. At our institution, the patient denied any 
specific complaints. In discussion with the transferring physician, 
it was determined that the patient initially presented for lower 
extremity pain and fatigue, and was found to have negative 
bilateral deep venous thrombosis studies.
On physical exam, the patient was a cachectic, elderly 
male found to be normothermic at 36.9º Celsius, with a blood 
pressure of 114/68 millimeters of mercury, heart rate of 88 
beats per minute, respiratory rate of 14 breaths per minute, and 
oxygen saturation of 95% on room air. Otherwise, he had an 
unremarkable exam with the exception of symmetric 1+ lower 
extremity edema without evidence of cellulitis. 
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What do we already know about this clinical 
entity? 
Pseudohyperkalemia is an in vitro increase 
in serum potassium associated with 
thrombocytosis and leukocytosis, processes 
that increase cell fragility and lysis.
What makes this presentation of disease 
reportable? 
Reported cases of pseudohyperkalemia, 
especially relating to unusual causes such as 
leukemia, contribute to the limited body of 
knowledge currently in the literature.
What is the major learning point? 
Differentiating true hyperkalemia from 
pseudohyperkalemia is imperative as the 
inappropriate treatment of pseudohyperkalemia 
can lead to devastating hypokalemia.
How might this improve emergency 
medicine practice? 
Maintaining suspicion for 
pseudohyperkalemia in the appropriate 
clinical setting will decrease the frequency of 
inappropriate treatment.
Upon arrival, repeat laboratories demonstrated stable 
hyperleukocytosis of 279,000 cells/μL, but also a potassium 
of 6.7 microequivalent per liter (mEq/L) (reference range: 3.4-
5.2 mEq/L) without reported visible hemolysis. It should be 
noted the patient had a reported potassium of 4.5 mEq/L at the 
outside hospital earlier that day. The patient continued to deny 
any symptoms, and an electrocardiogram (ECG) was obtained 
that did not show evidence of hyperkalemia. One liter of 
normal saline and furosemide 20 milligrams were given 
intravenously with a repeat potassium elevated to 9.4 mEq/L, 
this time with some hemolysis. Given the rapidly escalating 
potassium level despite an initial trial of therapy and a normal 
ECG, a point-of-care potassium was drawn and returned as 
3.8 mEq/L. Since this value was more consistent with the 
outside hospital level and there was a lack of clinical and ECG 
findings to suggest hyperkalemia, no further interventions 
were performed in the emergency department.
Over the course of his hospitalization, the patient had 
multiple elevated potassium levels, usually with interpreted 
hemolysis, although occasionally without reported hemolysis. 
In fact, the patient had his apparently elevated potassium treated 
with a hyperkalemia cocktail of calcium gluconate, insulin, 
dextrose, and sodium polystyrene on at least one occasion during 
his hospital stay. The patient never had physical manifestations of 
hyperkalemia nor were there ECG changes. 
DISCUSSION
In vivo hyperkalemia is a common electrolyte derangement 
typically seen in chronic kidney disease as well as in acute 
processes such as rhabdomyolysis and diabetic ketoacidosis. 
Conversely, pseudohyperkalemia is an in vitro increase in 
serum potassium. Hemolysis can occur during the pre-analytical 
process, particularly with mechanical trauma during venipuncture, 
prolonged tourniquet time, and fist clenching, all of which may 
cause extracellular movement of potassium from myocytes.2
Cases of pseudohyperkalemia associated with 
thrombocytosis and leukocytosis have been reported in the 
literature since the 1950s.1,3 Pseudohyperkalemia has been 
associated with hyperleukocytosis, more commonly in CLL 
in adults, but also acute lymphoblastic leukemia in children.4-9 
It is thought that hyperleukocytosis increases cell fragility, 
making cell lysis more common during specimen collection, 
particularly with smaller-bore needles, as well as transport 
and centrifugation. Since leukocytes are more prone to lysis 
than erythrocytes, laboratory detection may not be apparent 
if erythrocytes are unaffected. This may lead to the spurious 
reporting of elevated potassium without the expected caveat 
of hemolysis and explain why in our case the use of the 
point-of-care test showed a normal potassium. Moreover, at 
our institution, we use a pneumatic tube system to transport 
laboratory specimens, which would further increase the risk of 
fragile cell lysis compared to a bedside test without transport.
Although we highlight pseudohyperkalemia in the setting of 
hematologic malignancy, rarer etiologies of pseudohyperkalemia 
exist in the literature. There are cases of pseudohyperkalemia 
associated with postsplenectomy thrombocytosis following 
trauma as well as hepatosplenic schistosomiasis infection.10-11 
Familial pseudohyperkalemia is an autosomal dominant, 
albeit exceedingly rare, disorder in which erythrocyte plasma 
membranes exhibit temperature-dependent permeability of 
potassium in vitro.12 Although vastly different pathologies, it 
can be inferred that processes that promote cell fragility increase 
the risk of pseudohyperkalemia. Thus, clinical suspicion for 
pseudohyperkalemia should be maintained in patients with 
these predispositions. Likewise, underlying hematological 
disorders should be considered in patients with suspected 
pseudohyperkalemia without known disease.
Differentiating true hyperkalemia from 
pseudohyperkalemia is important as hyperkalemia in 
patients with leukocytosis in the setting of known or 
suspected malignancy is concerning for tumor lysis 
syndrome (TLS), an oncologic emergency involving lysis 
of malignant cells and extracellular release of potassium 
and phosphate as well as the generation of uric acid. 
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Treatment of hyperkalemia in TLS is similar to that of 
hyperkalemia in other patients.
The inappropriate treatment of pseudohyperkalemia 
can lead to devastating hypokalemia. Nevertheless, 
multiple case reports as early as the 1980s have 
cited the inappropriate treatment of hyperkalemia in 
hyperleukocytosis.6,13 We aim to add to the body of 
knowledge of pseudohyperkalemia. Inappropriate treatment 
of pseudohyperkalemia can be detrimental. It is imperative 
that treatment be started with appropriate clinical suspicion 
rather than solely laboratory findings, which have inherent 
limitations and errors.
CONCLUSION
Differentiating true hyperkalemia, a medical emergency, 
from pseudohyperkalemia, where treatment can be detrimental 
is important for the EP. In order to do this, the EP needs to be 
familiar with the plethora of causes of pseudohyperkalemia 
from the more common hemolysis to the much rarer 
thrombosis and extreme leukocytosis or thrombocytosis.
The authors attest that their institution requires neither 
Institutional Review Board approval, nor patient consent for 
publication of this case report. Documentation on file.
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